Dystonia News and Research

RSS

Dystonia is a neurological movement disorder, in which sustained muscle contractions cause twisting and repetitive movements or abnormal postures.

First-in-the-U.S. clinical trial uses deep brain stimulation to tackle opioid addiction

The West Virginia University Rockefeller Neuroscience Institute and WVU Medicine, today (Nov. 5) announced the launch of a first-in-the-U.S. clinical trial using deep brain stimulation for patients suffering from treatment-resistant opioid use disorder.

5 Nov 2019

New review provides knowledge about sex-related differences in Parkinson's disease

There is growing evidence that Parkinson's disease affects women and men differently. In this insightful review, published in the Journal of Parkinson's Disease, scientists present the most recent knowledge about these sex-related differences and highlight the significance of estrogens, which play an important role in the sex differences in PD.

25 Sep 2019

New oral splint can reduce tics in children and adults with Tourette syndrome

Tourette syndrome is a neurological disorder characterized by vocal and motor tics, which can contribute to anxiety, depression, and low self-esteem.

10 Sep 2019

Study suggests therapeutic solutions for pantothenate kinase-associated neurodegeneration

The scientific research team from the Universidad Pablo de Olavide led by doctor José Antonio Sánchez Alcázar has published a new study in the international magazines Molecular Neorubiology and Neural Regeneration Research.

11 Jun 2019

Researchers use brain connectome to reassess neuroimaging findings of Alzheimer's disease

Already affecting more than five million Americans older than 65, Alzheimer's disease is on the rise and expected to impact more than 13 million people by 2050.

17 Dec 2018

Russian scientists create hardware-information system for brain disorders treatment

A team of scientists of Ural Federal University headed by Prof. Vladimir Kublanov created a hardware-information system for brain disorders prophylaxis and treatment unrivaled both in Russia and throughout the world.

13 Dec 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

Neuroscientists use brain lesion network mapping to identify anatomical origins of free will

Long the domain of philosophy and religion, free will has also been defined by scientists as a combination of two cognitive processes - the desire to act (or volition) and the sense of responsibility for our actions (or agency.)

3 Oct 2018

Salk researchers clarify relationship of two neuron types to psychiatric and movement disorders

If 95 percent of your neighbors are chatty and outgoing, you probably know more about them than the 5 percent who are reclusive and shy.

3 May 2018

Lightning may pose potential danger to patients receiving deep brain stimulation

Patients receiving deep brain stimulation are warned that their neurostimulators may dysfunction when confronted by electromagnetic fields that can be generated by particular electrical devices found at work, home, and in the hospital.

2 May 2018

Gladstone scientists uncover how fast-spiking interneurons improve procedural learning

Even if you haven't ridden your bike in years, you probably remember how to do so without giving it much thought.

9 Feb 2018

The London Clinic exhibits innovative technology to treat Parkinson’s disease at Arab Health

A pioneering technology that allows patients to control their Parkinson’s disease symptoms using an iPod will be showcased at Arab Health by a renowned UK hospital.

16 Jan 2018

Brain activity patterns linked to clinical outcomes achieved through DBS in dystonia patients

Dystonia affects more than 500,000 people across Europe. Globally, it is the third most common movement disorder after Parkinson's disease and essential tremor.

22 Dec 2017

Study investigates how brain lesions can contribute to criminal behavior

New research published in the Proceedings of the National Academy of Sciences indicates that lesions to brain areas in individuals exhibiting criminal behavior all fall within a particular brain network involved in moral decision-making.

18 Dec 2017

OHSU study shows better clinical outcomes for deep brain stimulation while patients are asleep

Deep brain stimulation is a long-established surgical procedure that eases the effects of Parkinson's disease and essential tremor through pulses from tiny electrodes implanted in the brain. Currently, most surgeons around the world conduct this surgery while the patient is awake.

3 Nov 2017

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion Pharmaceuticals Inc. today announced post-hoc analysis results of a positive Phase 3 placebo-controlled clinical study, as well as interim data from a long-term open-label extension study evaluating Latuda (lurasidone HCI) in children and adolescents (10 to 17 years of age) with major depressive episodes associated with bipolar I disorder (bipolar depression).

28 Oct 2017

Bionic vision restoration: could future technologies restore sight?

The brain is very plastic, which means that the brain is able to adapt to new signals. In the case of bionic vision restoration, the photoreceptors have died, the brain is not receiving anything biologically, and you are going to then send something which is artificial, prosthetic, and has been created outside the body.

21 Aug 2017

Scientists use magnetic nanoparticles to trigger activity deep inside the brain

Scientists have used magnetism to activate tiny groups of cells in the brain, inducing bodily movements that include running, rotating and losing control of the extremities -- an achievement that could lead to advances in studying and treating neurological disease.

17 Aug 2017

Botulinum neurotoxin type X holds potential to open up new field of toxin therapeutics

Botulinum toxins are currently used on more than 80 medical conditions including Muscle spasms, Overactive bladder, Chronic migraine, Cervical dystonia, Sweating and Cerebral Palsy (CP).

3 Aug 2017

Insomnia drug appears to have opposite effect for patients with neurologic conditions

In a new systematic review in JAMA Neurology, Michigan Medicine researchers found reason to further explore the surprising effects of zolpidem that have been observed outside the scope of its primary Food and Drug Administration approval.

27 Jun 2017